Search results
Results From The WOW.Com Content Network
Georges Jean Franz Köhler (German pronunciation: [ˈʒɔʁʃ ˈkøːlɐ] ⓘ; 17 April 1946 – 1 March 1995) was a German biologist.. Together with César Milstein and Niels Kaj Jerne, Köhler won the Nobel Prize in Physiology or Medicine in 1984, "for work on the immune system and the production of monoclonal antibodies".
Sir Gregory Paul Winter CBE FRS FMedSci (born 14 April 1951) [6] [7] is a Nobel Prize-winning English molecular biologist best known for his work on the therapeutic use of monoclonal antibodies. His research career has been based almost entirely at the MRC Laboratory of Molecular Biology and the MRC Centre for Protein Engineering , in Cambridge ...
This list of over 500 monoclonal antibodies includes approved and investigational drugs as well as drugs that have been withdrawn from market; consequently, the column Use does not necessarily indicate clinical usage. See the list of FDA-approved therapeutic monoclonal antibodies in the monoclonal antibody therapy page.
In addition to the Nobel Prize in 1984, Milstein was elected a Fellow of the Royal Society (FRS) in 1975, [3] was a fellow of Darwin College, Cambridge, from 1980 to 2002, awarded the Louisa Gross Horwitz Prize from Columbia University in 1980, he was awarded the Wolf Prize in Medicine in 1980, he won the Copley Medal in 1989, and became a ...
This underpinned the concept of monoclonal antibodies and monoclonal drug conjugates. Ehrlich and Élie Metchnikoff received the 1908 Nobel Prize for Physiology or Medicine for providing the theoretical basis for immunology. By the 1970s, lymphocytes producing a single antibody were known, in the form of multiple myeloma – a cancer affecting ...
Among the 892 Nobel laureates, 48 have been women; the first woman to receive a Nobel Prize was Marie Curie, who received the Nobel Prize in Physics in 1903. [12] She was also the first person (male or female) to be awarded two Nobel Prizes, the second award being the Nobel Prize in Chemistry, given in 1911. [11]
Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Ramucirumab is a recombinant human monoclonal antibody and is used in the treatment of advanced malignancies. [18] In childhood lymphoma, phase I and II studies have found a positive effect of using antibody therapy. [19]
1901 Emil Adolf von Behring (1854-1917), "for his serum therapy to treat diphtheria" (First ever Nobel Prize in Physiology or Medicine) 1908 Eli Metchnikoff (1845-1916) and Paul Ehrlich (1854-1915), "for study of the immune system" 1919 Jules Bordet (1870-1961), "for discovery of the complement system in the immune system"